Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Eupraxia Pharmaceuticals (EPRX) vs. Competitors

83 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
TSE:EPRXEupraxia PharmaceuticalsCAD 8.78CAD 595.55M-5.89-0.11%Strong BuyUnlock the TSE:EPRX analyst price target with TipRanks PremiumTSE:EPRXUnlock the TSE:EPRX top-analyst price target with TipRanks Premium
TSE:DRUGBright Minds BiosciencesCAD 28.92CAD 292.85M-9.97-64.29%Strong BuyUnlock the TSE:DRUG analyst price target with TipRanks PremiumTSE:EPRX vs TSE:DRUGUnlock the TSE:DRUG top-analyst price target with TipRanks Premium
TSE:MYNDMYND Life SciencesCAD 0.07CAD 3.35M-2.180.00%―Unlock the TSE:MYND analyst price target with TipRanks PremiumTSE:EPRX vs TSE:MYNDUnlock the TSE:MYND top-analyst price target with TipRanks Premium
TSE:MBIOMindbio Therapeutics Corp.CAD 0.10CAD 691.89K-0.05-92.40%―Unlock the TSE:MBIO analyst price target with TipRanks PremiumTSE:EPRX vs TSE:MBIOUnlock the TSE:MBIO top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
TSE:EPRXEupraxia Pharmaceuticals8.78-0.10-1.13%
TSE:DRUGBright Minds Biosciences28.92-51.75-64.15%
TSE:MYNDMYND Life Sciences0.070.000.00%
TSE:MBIOMindbio Therapeutics Corp.0.10-0.79-89.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts